Research Grade Anti-SARS-CoV-2 RBD antibody (EY6A)Anti-SARS-CoV-2 RBD antibody (EY6A) ( VK565063 ) is a research-grade recombinant antibody targeting Spike glycoprotein . Produced in mammalian cells with native-like glycosylation. Highlights Research Grade — For PK/PD studies, assay development, and ADA research. Native Glycosylation — Mammalian expression ensures native-like patterns. Спецификация| Species reactivity | SARS-CoV-2 (2019-nCoV) | | Applications | ELISA, Bioactivity: FACS, Functional assay, Research in vivo | | Form | Liquid | | Storage | -20℃ | | Product category | Biosimilar | | Target | Spike glycoprotein, S glycoprotein, E2, Peplomer protein, Spike protein S1, Spike protein S2, Spike protein S2', S, 2 | | Accession | P0DTC2 | | Host species | Human | | | |
Информация для заказа| Область использования: | Производство: | Puda Scientific | | Метод: | Иммуногистохимия | | Объем: | 100ug | | Кат. номер: | PD-A26-416-100 | | Цена (с НДС 22%): | по запросу | В корзину  | Наименование: Research Grade Anti-SARS-CoV-2 RBD antibody (EY6A).
Примечание: |
|
